Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1448335

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1448335

Global Transcatheter Devices Market Size, Share, Growth Analysis, By Product(Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices), By Application(Cardiovascular, Oncology) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Transcatheter Devices Market size was valued at USD 12.32 billion in 2022 and is poised to grow from USD 13.99 billion in 2023 to USD 38.66 billion by 2031, growing at a CAGR of 13.55% in the forecast period (2024- 2031).

The global market for transcatheter devices is showing interesting changes in the healthcare field. These devices are becoming more popular because they offer a way to perform surgeries with smaller incisions, which means less discomfort and faster recovery for patients. They're used for various health issues, like heart problems, without needing to do traditional open surgeries. The market is growing because more people are getting older and having chronic illnesses, and medical technology is getting better. People, including doctors and patients, want treatments that help them recover faster and have fewer problems afterward, and transcatheter devices fit the bill. However, there are challenges to the market's growth, like rules about using the devices, getting paid for using them, and needing special training to use them properly. Still, ongoing research and new ideas about how to make these devices better, along with cooperation between doctors and device makers, will shape the future of the global market for transcatheter devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Devices Market Segmental Analysis

The global Transcatheter Devices Market is segmented on the basis of Application, Product, and Region. By Application, the market is segmented into Cardiovascular, Oncology, Neurology, Urology, and Others. By Product, the market is segmented into Transcatheter Embolization and Occlusion Devices, Transcatheter Replacement Devices, Transcatheter Repair Devices. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Transcatheter Devices Market

As medical technology advances, there's a bigger focus on procedures that make patients less uncomfortable, shorten hospital stays, and speed up recovery times. Transcatheter devices, like stents, valves, and embolization devices, are vital for performing less invasive procedures in different medical fields. These devices let doctors reach specific areas in the body through small cuts, meaning they don't need to do traditional open surgeries. Because patients want procedures that help them recover faster with fewer problems, the use of transcatheter devices is increasing. This trend is pushing innovation and changing how treatments are done in healthcare.

Restraints in the Global Transcatheter Devices Market

Creating and selling these new medical devices usually involves a lot of clinical trials and getting approval from regulators. Transcatheter procedures are complicated, and using new technology can have risks, so it's important to carefully check them to keep patients safe. Dealing with different rules in different places can slow down getting products out and make it more expensive for companies. Because of this, these rules can slow down how quickly new devices are made and get into the market, which is a big restraint for the global market for transcatheter devices.

Market Trends of the Global Transcatheter Devices Market

TAVR (Transcatheter Aortic Valve Replacement) has become increasingly popular as a less invasive option compared to traditional open-heart surgery for treating aortic valve diseases, especially in older patients and those at high risk during surgery. This trend is driven by the procedure's benefits of faster recovery, shorter hospital stays, and fewer complications, which align with patients' preferences for less invasive treatments. With the growing number of elderly patients and advancements in TAVR techniques, its use is expanding across different regions. Additionally, ongoing research and development are improving TAVR technologies, making them more widely applicable and ensuring better patient outcomes in the global transcatheter devices market.

Product Code: SQMIG35A2584

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Transcatheter Devices Market by Product

  • Market Overview
  • Transcatheter Embolization and Occlusion Devices
  • Transcatheter Replacement Devices
  • and Transcatheter Repair Devices

Global Transcatheter Devices Market by Application

  • Market Overview
  • Cardiovascular
  • Oncology
  • Neurology
  • Urology
  • and Others

Global Transcatheter Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • CryoLife, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • enaValve Technology, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neovasc Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meril Life Sciences Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Symetis SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Venus Medtech (Hangzhou) Inc. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • W.L. Gore & Associates (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JenaValve Technology, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xeltis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endologix Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosensors International Group, Ltd. (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Direct Flow Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Transcatheter Technologies GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!